5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.24▲ | 1.24▲ | 1.23▲ | 1.19▲ | 1.36▼ |
MA10 | 1.23▲ | 1.22▲ | 1.20▲ | 1.25▼ | 1.71▼ |
MA20 | 1.19▲ | 1.19▲ | 1.21▲ | 1.51▼ | 1.54▼ |
MA50 | 1.20▲ | 1.20▲ | 1.24▼ | 1.87▼ | 1.30▼ |
MA100 | 1.22▲ | 1.26▼ | 1.49▼ | 1.52▼ | 1.17▲ |
MA200 | 1.33▼ | 1.62▼ | 1.78▼ | 1.32▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.007▲ | 0.008▲ | 0.011▲ | -0.018▼ | -0.090▼ |
RSI | 54.924▲ | 54.336▲ | 52.968▲ | 37.840▼ | 44.744▼ |
STOCH | 79.894 | 86.045▲ | 78.807 | 28.512 | 26.968 |
WILL %R | -14.286▲ | -12.000▲ | -11.111▲ | -74.734 | -85.000▼ |
CCI | 72.329 | 82.295 | 73.673 | -42.700 | -98.945 |
MA | $NRSN Price Crossed Above MA(7) | Set Alert |
Friday, August 01, 2025 06:00 AM
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company developing novel treatments for severe neurodegenerative diseases, today provided business ...
|
Friday, August 01, 2025 06:00 AM
CAMBRIDGE, Mass., July 31, 2025 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company developing novel treatments for severe ...
|
Tuesday, July 01, 2025 09:08 AM
Nasdaq handily beat the New York Stock Exchange in stock market listings during the first half of 2025, buoyed by blockbuster initial public offerings of big names like CoreWeave and Chime and a ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
18/08/25 | 1.20 | 1.255 | 1.20 | 1.24 | 150,761 |
15/08/25 | 1.15 | 1.2299 | 1.15 | 1.19 | 169,619 |
14/08/25 | 1.25 | 1.29 | 1.03 | 1.17 | 479,347 |
13/08/25 | 1.13 | 1.31 | 1.13 | 1.25 | 427,889 |
12/08/25 | 1.13 | 1.22 | 1.08 | 1.12 | 596,438 |
11/08/25 | 1.28 | 1.28 | 1.13 | 1.20 | 306,571 |
08/08/25 | 1.30 | 1.3299 | 1.22 | 1.26 | 144,955 |
07/08/25 | 1.35 | 1.39 | 1.25 | 1.30 | 227,198 |
06/08/25 | 1.38 | 1.52 | 1.33 | 1.34 | 382,535 |
05/08/25 | 1.27 | 1.39 | 1.2301 | 1.38 | 387,543 |
|
|
||||
|
|
||||
|
|